Clinical Trial Update: The Effects of Weight Loss on Neuroadrenergic Function [NA]

View source ↗

Summary

A clinical trial update from Baker Heart Research Institute investigating how weight loss influences neuroadrenergic function in obesity and related metabolic d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Baker Heart Research Institute | Conditions: Obesity, Type 2 Diabetes | NA | Status: UNKNOWN